MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Determination of metabotropic glutamate receptor 2/3 distribution with [3H]-LY-341,495 in Parkinson’s disease patients with visual hallucinations

    D. Bedard, E. Kim, I. Frouni, P. Huot (Montreal, Canada)

    Objective: To determine the distribution and levels of metabotropic glutamate 2/3 (mGlu2/3) receptors in brain tissue from patients with Parkinson’s disease (PD) with visual hallucinations (VHs).…
  • 2022 International Congress

    Socio-economic factors influencing Parkinson’s disease self-management

    L. Ambrosio, C. Rodríguez-Blazquez, M. Rodriguez Violante, T. Arakaki, N. Garretto, M. Serrano-Dueñas, I. Ibañez (Southampton, United Kingdom)

    Objective: To identify the socioeconomical factors associated with self-management Parkinson’s disease (PD). Background: Understanding and evaluating how PD patients manage their disease is paramount to…
  • 2022 International Congress

    CAREGIVERS BURDEN IN CARING FOR PERSONS WITH PARKINSON’S DISEASE: A SURVEY FROM A TEACHING HOSPITAL IN GHANA

    M. Agoriwo, D. Markwei, E. Womorde (Ho, Ghana)

    Objective: To determine the burden of caregivers in caring for persons with Parkinson’s disease (PD) and establish the relationship between the burden of care and…
  • 2022 International Congress

    Longitudinal study of Parkinson’s disease-related pattern with resting state functional MRI

    A. Vo, N. Nguyen, D. Eidelberg (Manhasset, USA)

    Objective: To validate the previously characterized resting-state fMRI (rs-fMRI) Parkinson’s disease (PD)-related pattern, termed fPDRP, in a large multi-site PD imaging database, and to assess…
  • 2022 International Congress

    Acute polyneuropathy in patients with Parkinson’s disease treated with LCIG

    P. Havránková, R. Jech, M. Baláž, V. čapek, K. Gmitterová, M. Grófik, V. Haň, M. Kaiserová, P. Kaňovský, J. Klempíř, E. Kurča, M. Minár, J. Necpál, I. Rektorová, J. Roth, E. Růžička, M. škorvánek, P. Valkovič (Praha 2, Czech Republic)

    Objective: The aim of the study was to determine whether the daily dose of levodopa equivalent daily dose (LEDD) before and after starting levodopa/carbidopa intestinal…
  • 2022 International Congress

    Anthropometric Changes in Parkinson’s Disease: Canadian Longitudinal Study on Aging

    S. Zolfaghari, A. Pelletier, R. Postuma (Montreal, Canada)

    Objective: To explore the predictive role of anthropometric changes and development of Parkinson’s Disease (PD). Background: There is a tendency to lose weight in PD,…
  • 2022 International Congress

    Correlation between cognitive/emotional factors and postural control in patients with Parkinson’s disease

    A. Bitiati, C. de Oliveira, C. de Souza, A. Batista, R. Marquesini, A. Moreira-Neto, C. Batista, L. Teixeira, A. Pardini, D. Coelho (Santo André, Brazil)

    Objective: This study aims to find associations between executive function, anxiety, depression, and reactive and anticipatory postural control domains. Background: Cognition and emotional state are…
  • 2022 International Congress

    Genetic correlation and potential causal relationship between inflammatory bowel disease and Parkinson’s disease

    S. Grover, E. Wacker, A. Kumar-Sreelatha, A. Elbaz, R. Krüger, T. Gasser, D. Ellinghaus, M. Sharma (Tuebingen, Germany)

    Objective: The present study investigates shared genetic etiology between inflammatory bowel disease (IBD) and Parkinson’s disease (PD) using correlation and causality-based approaches. Background: The role…
  • 2022 International Congress

    Subgroup analyses by Unified Parkinson’s Disease Rating Scale Part III (UPDRS-III) of patients treated with levodopa inhalation powder 84mg or placebo to treat OFF symptoms in patients with Parkinson’s disease (PD)

    D. Grosset, P. Zhao, R. Marini, R. Cohen, B. Blank (Glasgow, United Kingdom)

    Objective: An analysis of the proportion of patients who turned ON after levodopa inhalation powder (CVT-301) 84mg treatment vs placebo, compared across subgroups of patients…
  • 2022 International Congress

    Clinical presentation of SNCA Duplication Parkinsonism in a Family Kindred

    K. Dent, M. Rochman, D. Kremens, J. Ratliff (Philadelphia, USA)

    Objective: To report phenotype variability in a family with SNCA duplication associated Parkinsonism. Background: Pathogenic variants in SNCA, the gene coding for α-synuclein, cause familial…
  • « Previous Page
  • 1
  • …
  • 241
  • 242
  • 243
  • 244
  • 245
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley